Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
Ontology highlight
ABSTRACT: Microglia, as cellular mediators of neuroinflammation, are implicated in the pathogenesis of a wide range of neurodegenerative diseases. Positron emission tomography (PET) imaging of microglia has matured over the last 20 years, through the development of radiopharmaceuticals targeting several molecular biomarkers of microglial activation and, among these, mainly the translocator protein-18 kDa (TSPO). Nevertheless, current limitations of TSPO as a PET microglial biomarker exist, such as low brain density, even in a neurodegenerative setting, expression by other cells than the microglia (astrocytes, peripheral macrophages in the case of blood brain barrier breakdown), genetic polymorphism, inducing a variation for most of TSPO PET radiopharmaceuticals' binding affinity, or similar expressi
SUBMITTER: Tronel C
PROVIDER: S-EPMC5412386 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA